4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide
C25H39N3O3 — CID 155049615
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide
4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide (PubChem CID 155049615) has the molecular formula C25H39N3O3 and a molecular weight of 429.61 g/mol. Its IUPAC name is 4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 155049615 |
| Molecular Formula | C25H39N3O3 |
| Molecular Weight | 429.61 g/mol |
| Exact Mass | 429.30 |
| IUPAC Name | 4-[2-[[ethyl(2-oxaspiro[3.5]nonan-7-yl)amino]methyl]-1-methoxy-6-methylcyclohexyl]pyridine-2-carboxamide |
| SMILES | CCN(CC1CCCC(C)C1(OC)c1ccnc(C(N)=O)c1)C1CCC2(CC1)COC2 |
| InChI | InChI=1S/C25H39N3O3/c1-4-28(21-8-11-24(12-9-21)16-31-17-24)15-20-7-5-6-18(2)25(20,30-3)19-10-13-27-22(14-19)23(26)29/h10,13-14,18,20-21H,4-9,11-12,15-17H2,1-3H3,(H2,26,29) |
| InChIKey | OSIDDCUEMQNCNK-UHFFFAOYSA-N |
| XLogP | 3.74 |
| TPSA | 77.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.61 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155049615 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.